10.6084/m9.figshare.c.3635498_D1.v1
Kavitha Krishnan
Kavitha
Krishnan
Laura Baglietto
Laura
Baglietto
Carmel Apicella
Carmel
Apicella
Jennifer Stone
Jennifer
Stone
Melissa Southey
Melissa
Southey
Dallas English
Dallas
English
Graham Giles
Graham
Giles
John Hopper
John
Hopper
Additional file 1: of Mammographic density and risk of breast cancer by mode of detection and tumor size: a case-control study
Springer Nature
2016
Mammographic density
Breast cancer
Detection mode
Tumor size
2016-06-18 05:00:00
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Mammographic_density_and_risk_of_breast_cancer_by_mode_of_detection_and_tumor_size_a_case-control_study/4438712
Table S1. Risk of breast cancer for BMI and mammographic measures by detection mode, excluding HRT users. Table S2 Risk of breast cancer for BMI and mammographic measures by detection mode and tumor size, excluding HRT users. Table S3 Risk of interval versus screen-detected cancer for BMI and mammographic measures, excluding HRT users. Table S4 Risk of breast cancer for BMI and mammographic measures by detection mode, excluding cases (and matched controls) diagnosed within 2 years of mammogram. Table S5 Risk of breast cancer for BMI and mammographic measures by detection mode and tumor size, excluding cases (and matched controls) diagnosed within 2 years from mammogram. Table S6 Risk of interval versus screen-detected cancer for BMI and mammographic measures, excluding cases (and matched controls) diagnosed within 2 years from mammogram. Table S7 Risk of breast cancer for BMI and mammographic measures by detection mode, excluding cases diagnosed between 1 and 2 years after negative screening, and their matching controls. Table S8 Risk of breast cancer for BMI and mammographic measures by detection mode and tumor size, excluding cases diagnosed between 1 and 2 years after negative screening, and their matching controls. Table S9 Risk of interval versus screen-detected cancer for BMI and mammographic measures, excluding cases diagnosed between 1 and 2 years after negative screening, and their matching controls. (DOCX 61 kb)